Annual report pursuant to Section 13 and 15(d)

13. INCOME TAXES (Details-Income tax provision)

v2.4.1.9
13. INCOME TAXES (Details-Income tax provision) (USD $)
12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Income Tax Disclosure [Abstract]    
Income tax benefit at statutory rate $ (444,442)us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate $ (782,067)us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
State taxes (94,475)us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes (132,094)us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes
Stock-based compensation 2,293,891us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost 0us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
Investment in KannaLife Sciences (2,567,000)us-gaap_IncomeTaxReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary 0us-gaap_IncomeTaxReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary
Amortization of discount on convertible note 200,421us-gaap_IncomeTaxReconciliationNondeductibleExpenseAmortization 3,880us-gaap_IncomeTaxReconciliationNondeductibleExpenseAmortization
Permanent differences (8,114)us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther 0us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther
Other 69,948us-gaap_IncomeTaxReconciliationOtherAdjustments 0us-gaap_IncomeTaxReconciliationOtherAdjustments
Change in valuation allowance 549,771us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance 910,281us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
Tax provision $ 0us-gaap_IncomeTaxExpenseBenefit $ 0us-gaap_IncomeTaxExpenseBenefit